News

ALK Welcomes Edward Jordan as New EVP of North America Operations

ALK Welcomes Edward Jordan as New EVP of North America Operations

ALK Announces Edward Jordan as New Executive Vice President

In a significant leadership move, ALK (Copenhagen: ALK B / LSE: 0OIR) has appointed Edward Jordan as the Executive Vice President (EVP) and head of Commercial Operations in North America. This strategic decision aims to bolster the company’s leadership team, reflecting its commitment to enhancing execution in the key markets of Europe and North America.

Edward Jordan’s Extensive Experience

Edward Jordan joins ALK with over 30 years of experience in the biopharmaceutical industry. His impressive resume includes prominent roles at well-respected firms such as Merck (Schering-Plough), Teva Pharmaceuticals, and DBV Technologies. Throughout his career, he has developed a deep expertise in allergy and immunology, specifically contributing to the development of popular allergy medications like Claritin and Clarinex, as well as innovative solutions like Viaskin.

Jordan's background positions him as an asset to ALK. His knowledge of the emerging food allergy market alongside his proven track record in commercial strategy, product launches, and market development will be invaluable as ALK seeks to strengthen its foothold in North America.

Leadership Insights from ALK’s CEO

Peter Halling, President and CEO of ALK, expressed enthusiasm about Jordan’s appointment. He highlighted the importance of commercial execution, citing recent successful launches of allergy immunotherapy tablets for children and nasal adrenaline sprays. Halling emphasized that Jordan's vast experience in driving commercial growth and his understanding of the North American market align perfectly with ALK’s strategic objectives.

Halling stated, “Ed joins ALK with extensive experience in leading commercial growth, commercialising therapies, and advancing care for patients with allergic and immunologic conditions. We are very pleased to welcome Ed to ALK’s Executive Leadership Team where his pharma and market expertise will be greatly appreciated.”

Jordan’s Vision for ALK

Upon his selection, Jordan expressed his excitement about joining ALK at this crucial phase in its growth trajectory. He remarked on ALK’s strong presence in the allergy sector and their commitment to treating allergy and associated conditions effectively. Jordan looks forward to leveraging his experience to enhance commercial operations, thereby expanding access to ALK’s innovative products across North America.

Executive Leadership Team at ALK

Following this recent appointment, ALK’s Executive Leadership Team now includes:

  • Peter Halling, President & CEO
  • Claus Steensen Sølje, EVP & CFO
  • Henriette Mersebach, EVP, R&D
  • Christian G. Houghton, EVP, Product Supply
  • Flora Beiche-Scholz, EVP, Commercial Operations Europe
  • Edward Jordan, EVP, Commercial Operations North America
  • Lika Thiesen, EVP, Global People & Organisation
  • Jacob Glenting, SVP, Global Strategy & Corporate Development and Global Marketing
  • Jan Engel, SVP, Global Quality

About ALK

ALK is a premier global specialty pharmaceutical company dedicated to the research and development of innovative treatments for allergy and allergic asthma. With its headquarters in Hørsholm, Denmark, ALK employs a workforce of approximately 2,800 individuals globally. The company has a significant presence in the marketplace through the manufacture and provision of allergy immunotherapy (AIT) treatments, acute anaphylaxis therapies, and a suite of support services for healthcare providers and allergy sufferers.

For those interested in learning more about ALK or discussing potential inquiries, please reach out to:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media Contact: Maiken Riise Andersen, tel. +45 5054 1434

Frequently Asked Questions

What is the new role of Edward Jordan at ALK?

Edward Jordan has been appointed as the Executive Vice President and head of Commercial Operations in North America at ALK.

How many years of experience does Edward Jordan have?

Edward Jordan brings over 30 years of biopharmaceutical experience, including significant roles in major pharmaceutical companies.

What is ALK’s primary focus?

ALK specializes in allergy and allergic asthma treatments, providing innovative allergy immunotherapy solutions and related services.

Who is ALK’s CEO?

Peter Halling serves as the President and CEO of ALK, overseeing the company's strategic direction and management.

Where is ALK headquartered?

ALK is headquartered in Hørsholm, Denmark, and employs approximately 2,800 people globally.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 1

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 1

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 2

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 2

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading

Top 5 Most Recently Viewed Articles

Rallybio Faces 52-Week Low as Strategic Shifts Unfold

Updated Category News Views 90

Rallybio's Stock Decline and Future Prospects In a stark reflection of the challenges in the biopharmaceutical sector, Rallybio Corporation (RLYB) has seen its stock plummet to a 52-week low of $1.08. This significant downturn comes as the stock value has decreased by 70.11% over the past year. Investors are closely monitoring the situation as Rallybio, a company devoted...

Continue Reading
Hunter Nation Mobilizes $1.8 Million Campaign for Court Election

Updated Category News Views 274

Hunter Nation Launches a Major Campaign for Voter Activation Hunter Nation, a prominent grassroots organization focused on hunting advocacy, is set to energize conservative voters with a groundbreaking campaign worth over $1.8 million. This initiative aims at rallying support for Judge Brad Schimel as he runs for the Wisconsin Supreme Court, emphasizing the necessity of...

Continue Reading
Idorsia's QUVIVIQ Gains Approval for China Market Expansion

Updated Category News Views 306

Idorsia’s QUVIVIQ Secures Approval in China Idorsia Ltd. has reached a pivotal moment with the recent approval of QUVIVIQ, a revolutionary treatment for insomnia, now officially available in China. This achievement comes as Simcere Pharmaceuticals Group Ltd has successfully obtained the green light from the Chinese National Medical Products Administration for this...

Continue Reading
Corning Set to Announce Quarterly Earnings: What to Expect

Updated Category News Views 195

Corning Set to Announce Quarterly Earnings: What to Expect Corning (NYSE: GLW) is gearing up for its upcoming quarterly earnings release. Investors are keenly watching for insights that could indicate the company's current performance and future trajectory. Analysts have set an optimistic tone ahead of this announcement. Predictions suggest that Corning will report an...

Continue Reading
Transforming U.S. Public Sector: Embracing Modern Work Solutions

Updated Category News Views 137

Adapting to Change in the U.S. Public Sector Public sector organizations across the U.S. are increasingly committed to adopting modern workplace technologies as they navigate significant digital transformations. This shift is fueled by the necessity to respond to evolving operational demands and the expectations of their employees and constituents. A recent research...

Continue Reading